Pharma / Biotech

Bavencio Receives New Indication for Maintenance in Advanced Urothelial Carcinoma

The FDA granted a new indication for avelumab for the maintenance treatment of patients with locally advanced or metastatic urothelial carcinoma that has not progressed on first-line platinum-containing chemotherapy.

Source link

Related posts

Tailoring Nutrition to Special Patient Populations


CALENDULA (calendula officinalis flowering top) ointment [Laboratoires Boiron]


CITALOPRAM tablet, film coated [Denton Pharma, Inc. DBA Northwind Pharmaceuticals]


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy